Skip to main content
Top
Published in: Rheumatology International 3/2015

01-03-2015 | Short Communication - Observational Research

Characteristics of MPO-ANCA-positive granulomatosis with polyangiitis: a retrospective multi-center study in Japan

Authors: Nobuyuki Ono, Hiroaki Niiro, Akira Ueda, Takuya Sawabe, Hiroaki Nishizaka, Isao Furugo, Seiji Yoshizawa, Shigeru Yoshizawa, Hiroshi Tsukamoto, Chikako Kiyohara, Yoshifumi Tada, Takahiko Horiuchi

Published in: Rheumatology International | Issue 3/2015

Login to get access

Abstract

We studied the clinico-pathological differences among PR3-ANCA-positive granulomatosis with polyangiitis (PR3-GPA), MPO-ANCA-positive GPA (MPO-GPA) and microscopic polyangiitis (MPA). ANCA-associated vasculitis (AAV) was classified using the European Medicines Agency classification. We retrospectively analyzed 38 patients with GPA and 41 with MPA treated in eight hospitals in Japan. Of the patients with GPA, 17 were positive for MPO-ANCA, and 15 for PR3-ANCA. All patients with MPA were MPO-ANCA positive. The mean ages of those with MPO-GPA were 69.6 years old, 10 years older than those with PR3-GPA. The majority (82 %) of patients with MPO-GPA were woman, a significantly greater proportion than for PR3-GPA. We also found that ear, nose and throat (ENT), nervous system involvement were significantly more common in MPO-GPA, but renal function was less impaired than those with MPA. Both PR3-GPA and MPO-GPA relapsed more frequently than MPA, but overall survival was significantly better (P < 0.01 and P < 0.05, respectively). Univariate analysis identified the following factors as predictors of a poor prognosis: MPA (P < 0.01), pulmonary UIP pattern (P < 0.005) Cr ≥ 1.7 mg/dl (P < 0.01) and absence of ENT involvement (P < 0.05), which were characteristics of MPA. In our cohort, MPO-GPA was most likely to affect older women and was associated with otitis media, nervous system involvement, mild renal impairment and more favorable outcome. It is clinically useful to differentiate MPO-GPA from MPA and PR3-GPA in patients with AAV.
Literature
1.
go back to reference Kallenberg CG, Heeringa P, Stegeman CA (2006) Mechanisms of disease: pathogenesis and treatment of ANCA-associated vasculitides. Nat Clin Pract Rheum 2:661–670CrossRef Kallenberg CG, Heeringa P, Stegeman CA (2006) Mechanisms of disease: pathogenesis and treatment of ANCA-associated vasculitides. Nat Clin Pract Rheum 2:661–670CrossRef
2.
go back to reference Liu LJ, Chen M, Wang HY et al (2008) Evaluation of a new algorithm in classification of systemic vasculitis. Rheumatology (Oxford) 47:708–712CrossRef Liu LJ, Chen M, Wang HY et al (2008) Evaluation of a new algorithm in classification of systemic vasculitis. Rheumatology (Oxford) 47:708–712CrossRef
3.
go back to reference Lionaki S, Blyth ER, Falk RJ et al (2012) Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis. Arthritis Rheum 64:3452–3462CrossRefPubMedCentralPubMed Lionaki S, Blyth ER, Falk RJ et al (2012) Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis. Arthritis Rheum 64:3452–3462CrossRefPubMedCentralPubMed
5.
go back to reference Watts R, Lane S, Scott D et al (2007) Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 66:222–227CrossRefPubMedCentralPubMed Watts R, Lane S, Scott D et al (2007) Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 66:222–227CrossRefPubMedCentralPubMed
6.
go back to reference Raghu G, Collard HR, Schünemann HJ et al (2011) ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183:788–824CrossRefPubMed Raghu G, Collard HR, Schünemann HJ et al (2011) ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183:788–824CrossRefPubMed
7.
go back to reference Guillevin L, Pagnoux C, Le Toumelin P et al (2011) French Vasculitis Study Group (FVSG). The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort. Medicine (Baltimore) 90:19–27CrossRef Guillevin L, Pagnoux C, Le Toumelin P et al (2011) French Vasculitis Study Group (FVSG). The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort. Medicine (Baltimore) 90:19–27CrossRef
8.
go back to reference Lane SE, Watts RA, Scott DG et al (2005) Primary systemic vasculitis: clinical features and mortality. QJM 98:97–111CrossRefPubMed Lane SE, Watts RA, Scott DG et al (2005) Primary systemic vasculitis: clinical features and mortality. QJM 98:97–111CrossRefPubMed
9.
go back to reference Mohammad AJ, Jacobsson LT, Segelmark M et al (2007) Prevalence of Wegener’s granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg-Strauss syndrome within a defined population in southern Sweden. Rheumatology (Oxford) 46:1329–1337CrossRef Mohammad AJ, Jacobsson LT, Segelmark M et al (2007) Prevalence of Wegener’s granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg-Strauss syndrome within a defined population in southern Sweden. Rheumatology (Oxford) 46:1329–1337CrossRef
10.
go back to reference Mahr A, Girard T, Guillevin L et al (2001) Analysis of factors predictive of survival based on 49 patients with systemic Wegener’s granulomatosis and prospective follow-up. Rheumatology (Oxford) 40:492–498CrossRef Mahr A, Girard T, Guillevin L et al (2001) Analysis of factors predictive of survival based on 49 patients with systemic Wegener’s granulomatosis and prospective follow-up. Rheumatology (Oxford) 40:492–498CrossRef
11.
go back to reference Kim HW, Kim JW, Song YW et al (2013) The clinicopathologic characteristics of granulomatosis with polyangiitis (Wegener’s): a retrospective study of 45 patients in Korea. Mod Rheumatol 23:864–871CrossRefPubMed Kim HW, Kim JW, Song YW et al (2013) The clinicopathologic characteristics of granulomatosis with polyangiitis (Wegener’s): a retrospective study of 45 patients in Korea. Mod Rheumatol 23:864–871CrossRefPubMed
12.
go back to reference Guillevin L, Durand-Gasselin B, Jarrousse B et al (1999) Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum 42:421–430CrossRefPubMed Guillevin L, Durand-Gasselin B, Jarrousse B et al (1999) Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum 42:421–430CrossRefPubMed
14.
go back to reference Yamagata K, Usui J, Matsuo S et al (2012) ANCA-associated systemic vasculitis in Japan: clinical features and prognostic changes. Clin Exp Nephrol 16:580–588CrossRefPubMed Yamagata K, Usui J, Matsuo S et al (2012) ANCA-associated systemic vasculitis in Japan: clinical features and prognostic changes. Clin Exp Nephrol 16:580–588CrossRefPubMed
15.
go back to reference Ono N, Yoshihiro K, Ueda A et al (2013) Four cases of MPO-ANCA-positive vasculitis with otitis media, and review of the literature. Mod Rheumatol 23:554–563CrossRefPubMed Ono N, Yoshihiro K, Ueda A et al (2013) Four cases of MPO-ANCA-positive vasculitis with otitis media, and review of the literature. Mod Rheumatol 23:554–563CrossRefPubMed
16.
go back to reference Furuta S, Chaudhry AN, Jayne D et al (2014) Comparison of phenotype and outcome in microscopic polyangiitis between Europe and Japan. J Rheumatol 4:325–333CrossRef Furuta S, Chaudhry AN, Jayne D et al (2014) Comparison of phenotype and outcome in microscopic polyangiitis between Europe and Japan. J Rheumatol 4:325–333CrossRef
17.
go back to reference Yokoseki A, Saji E, Kawachi I et al (2014) Hypertrophic pachymeningitis: significance of myeloperoxidase anti-neutrophil cytoplasmic antibody. Brain 137:520–536CrossRefPubMed Yokoseki A, Saji E, Kawachi I et al (2014) Hypertrophic pachymeningitis: significance of myeloperoxidase anti-neutrophil cytoplasmic antibody. Brain 137:520–536CrossRefPubMed
18.
go back to reference Arulkumaran N, Periselneris N, Salama AD (2011) Interstitial lung disease and ANCA-associated vasculitis: a retrospective observational cohort study. Rheumatology (Oxford) 50:2035–2043CrossRef Arulkumaran N, Periselneris N, Salama AD (2011) Interstitial lung disease and ANCA-associated vasculitis: a retrospective observational cohort study. Rheumatology (Oxford) 50:2035–2043CrossRef
Metadata
Title
Characteristics of MPO-ANCA-positive granulomatosis with polyangiitis: a retrospective multi-center study in Japan
Authors
Nobuyuki Ono
Hiroaki Niiro
Akira Ueda
Takuya Sawabe
Hiroaki Nishizaka
Isao Furugo
Seiji Yoshizawa
Shigeru Yoshizawa
Hiroshi Tsukamoto
Chikako Kiyohara
Yoshifumi Tada
Takahiko Horiuchi
Publication date
01-03-2015
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 3/2015
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-014-3106-z

Other articles of this Issue 3/2015

Rheumatology International 3/2015 Go to the issue